LIFECORE BIOMEDICAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
LIFECORE BIOMEDICAL, INC. (LFCR) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $0 as of 2021-11-28, per its 10-Q filed 2022-01-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2024-03-20
- 2021-11-28: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2021-08-29: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2021-05-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $44.77M; Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed $45.10M.
- 2021-02-28: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $45.10M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed |
|---|---|---|
| 2021-11-28 | $0.00 10-Q · filed 2022-01-07 | |
| 2021-08-29 | $0.00 10-Q · filed 2021-10-05 | |
| 2021-05-30 | $44.77M 10-K · filed 2024-03-20 | $45.10M 10-K · filed 2021-07-29 |
| 2021-02-28 | $45.10M 10-K · filed 2024-03-20 | |
| 2020-11-29 | $45.10M 10-K · filed 2024-03-20 | |
| 2020-08-30 | $55.10M 10-K · filed 2024-03-20 | $56.90M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $56.90M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $61.30M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $61.30M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $61.10M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $61.10M 10-K · filed 2020-08-14 | |
| 2019-02-24 | $68.10M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $68.10M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $67.50M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $66.50M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $65.80M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $65.80M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $64.50M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $63.60M 10-K · filed 2018-08-09 | |
| 2017-02-26 | $63.40M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $62.70M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $62.70M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $62.70M 10-K/A · filed 2018-03-15 | |
| 2016-02-28 | $62.50M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $62.50M 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $62.30M 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $61.50M 10-K · filed 2016-08-01 | |
| 2015-03-01 | $61.10M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $59.00M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $50.80M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $39.60M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $37.70M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $37.30M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $35.00M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $29.60M 10-K · filed 2014-08-01 | |
| 2013-02-24 | $27.80M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $26.75M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $25.80M 10-Q/A · filed 2013-01-02 | $22.90M 10-Q · filed 2012-10-03 |
| 2012-05-27 | $21.50M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $20.39M 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $16.84M 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $15.71M 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $15.66M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |